Cipla Limited (NSE:CIPLA)

Market Cap	1.10T -4.5%
Revenue (ttm)	279.67B +4.7%
Net Income	45.46B -8.9%
EPS	56.25 -8.9%
Shares Out	807.78M
PE Ratio	24.11
Forward PE	25.51
Dividend	13.00 (0.98%)
Ex-Dividend Date	Jun 27, 2025

Volume	875,612
Average Volume	1,970,888
Open	1,350.00
Previous Close	1,356.40
Day's Range	1,340.10 - 1,356.00
52-Week Range	1,281.70 - 1,673.00
Beta	-0.05
RSI	42.85
Earnings Date	Jan 23, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 30,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CIPLA

Financial Performance

In fiscal year 2025, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.